Hypertrophic Cardiomyopathy is another heart muscle disease. It causes the heart muscle to thicken, especially in the left ventricle. This thickening can make it harder for the heart to pump blood out. It can sometimes block blood flow and cause chest pain or fainting.
Every report comes from a Lived member, sent anonymously.
Have you tried Toprol-XL / Lopressor (Metoprolol) for HCM (Hypertrophic Cardiomyopathy)?
Hypertrophic cardiomyopathy (HCM) is a condition, usually inherited, in which the heart muscle becomes abnormally thick. The thickening most often affects the wall between the two lower pumping chambers. A thicker, stiffer muscle leaves less room inside the main pumping chamber (the left ventricle) and makes it harder for the heart to relax and fill between beats. In many people, the thickened muscle also narrows the path blood takes as it leaves the heart. This is called obstructive HCM (sometimes HOCM), and it tends to cause more symptoms. In nonobstructive HCM, blood leaves the heart freely, but stiffness can still limit how well the heart works. When symptoms occur, the most common is shortness of breath with activity. Others include tiredness, chest pain, a pounding or irregular heartbeat (palpitations), dizziness and fainting, often brought on by exertion. HCM affects roughly 1 in 500 people, yet most are never diagnosed because many feel well. It matters because, although most people live a normal lifespan, a minority develop heart failure, atrial fibrillation or a dangerous heart rhythm that can cause sudden cardiac arrest, sometimes as the first sign of the condition.
Most HCM is caused by changes in genes that build the heart muscle's contracting machinery. It usually follows an autosomal dominant pattern: a parent with a disease-causing gene change has a 50% chance of passing it to each child. Inheriting the gene change does not guarantee the condition. Many carriers never develop thickening, and severity can differ widely even within one family. Genetic testing finds a responsible gene change in some people with HCM, more often when others in the family are affected; in many, no single genetic cause is found. Because HCM runs in families, a diagnosis in one person matters for parents, siblings and children. Guidelines recommend that these first-degree relatives be screened, either with genetic testing when the family's gene change is known or with periodic heart ultrasounds and electrocardiograms. High blood pressure, a narrowed aortic valve (aortic stenosis) and intense athletic training can also thicken the heart muscle, but that thickening is a response to extra workload rather than HCM itself. Telling these apart is part of the diagnosis. In people who already have HCM, dehydration, heavy meals, alcohol and hard exertion can bring on symptoms, especially in the obstructive form.
HCM is often first suspected because of a heart murmur, an abnormal electrocardiogram (ECG, a recording of the heart's electrical activity), symptoms, or a relative's diagnosis. Sometimes it turns up on imaging done for another reason. The main test is an echocardiogram, an ultrasound of the heart. It measures the thickness of the heart wall and shows whether blood flow out of the heart is blocked. In adults, HCM is generally diagnosed when part of the left ventricle wall is 15 millimeters thick or more and no other cause such as high blood pressure or valve disease explains it. A lower cutoff of 13 millimeters applies to relatives of someone with HCM and to people known to carry an HCM gene change. If the resting echo shows no blockage but symptoms appear with effort, an echo during exercise can reveal obstruction that only develops during activity. Cardiac MRI gives a more detailed picture of the muscle and can show scarring, which helps estimate the risk of dangerous rhythms. A Holter or patch monitor, worn for a day or longer, looks for irregular rhythms. Genetic testing is offered mainly so that relatives can be tested for the same gene change.
Treatment depends on whether the heart is obstructed, how much symptoms limit daily life, and the risk of serious rhythm problems. Some people need only regular monitoring for years. For symptoms, beta-blockers and calcium channel blockers such as verapamil or diltiazem are usually tried first. They slow the heart and help it relax and fill, which can ease breathlessness and chest pain. Diuretics (water pills) are used cautiously, mainly when fluid builds up. For obstructive HCM that still causes symptoms, a newer class called cardiac myosin inhibitors targets the overly forceful muscle contraction behind the disease. Mavacamten (Camzyos) and aficamten (Myqorzo) are approved to improve exercise capacity and symptoms. Because they can weaken the heart's pumping too much and cause heart failure, they require regular echocardiograms and are prescribed only through a restricted safety program, and other medicines must be checked for interactions. Whether they reduce long-term complications is not yet known. When obstruction remains severe despite medication, septal reduction removes or shrinks the thickened muscle. Septal myectomy is open-heart surgery to cut away part of the thick wall. Alcohol septal ablation is a catheter procedure that injects alcohol into a small artery to shrink that area, an option for people less suited to surgery. These procedures are best done at centers experienced in HCM. Preventing sudden death is a separate decision. Clinicians weigh risk factors such as a family history of sudden death, unexplained fainting, very thick muscle and scarring on MRI. People at high risk may receive an implantable cardioverter-defibrillator (ICD), a small device under the skin that detects a life-threatening rhythm and shocks the heart back to normal. Defibrillators are a major reason deaths from HCM have fallen sharply. Atrial fibrillation, an irregular rhythm common in HCM, carries a high stroke risk here, so guidelines recommend a blood thinner for anyone with HCM who develops it, regardless of the usual stroke-risk score.
HCM is lifelong, but its course varies widely. Many people have few or no symptoms and a life expectancy similar to people without the condition. Others develop symptoms gradually, often in adolescence or adulthood, and some develop complications such as atrial fibrillation or, less often, a weakening of the heart's pumping over many years. With current care, including defibrillators and treatment of obstruction, deaths from HCM have become uncommon. Follow-up with a cardiologist, ideally one experienced in HCM, usually means an echocardiogram and ECG at regular intervals, with rhythm monitoring and MRI from time to time. Sudden-death risk is reassessed periodically because it can change. Exercise is no longer simply forbidden. Light to moderate activity is generally encouraged and appears to improve fitness without raising rhythm problems, while plans for vigorous or competitive sport are made individually with the cardiologist. Staying well hydrated and limiting alcohol can reduce symptoms, and new medicines or supplements are worth checking with the care team, since some are not safe with HCM. A diagnosis also starts a family process, since relatives benefit from screening even if they feel well.
See a clinician about an evaluation if a close relative has HCM or died suddenly at a young age, or if you notice breathlessness, chest discomfort or a pounding heartbeat during activity that seems out of proportion. If you have HCM, contact your care team promptly for fainting or near-fainting (especially during or right after exercise), new or worsening chest pain, palpitations or an irregular heartbeat, or growing breathlessness, swelling or fatigue. Fainting can signal a dangerous rhythm and usually needs a prompt risk review. If someone with HCM suddenly collapses and is unresponsive or not breathing normally, call 911, start CPR and use an automated external defibrillator (AED) if one is available.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with HCM (Hypertrophic Cardiomyopathy) is like, what's helped you, or ask the community a question.